Correlation Between Virax Biolabs and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Keros Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Keros Therapeutics.
Diversification Opportunities for Virax Biolabs and Keros Therapeutics
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Virax and Keros is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Keros Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to under-perform the Keros Therapeutics. In addition to that, Virax Biolabs is 3.34 times more volatile than Keros Therapeutics. It trades about -0.1 of its total potential returns per unit of risk. Keros Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest 4,541 in Keros Therapeutics on August 24, 2024 and sell it today you would earn a total of 843.00 from holding Keros Therapeutics or generate 18.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Keros Therapeutics
Performance |
| Timeline |
| Virax Biolabs Group |
| Keros Therapeutics |
Virax Biolabs and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Keros Therapeutics
The main advantage of trading using opposite Virax Biolabs and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |